Four kinds of traditional Chinese exercise therapy in the treatment of type 2 diabetes: a systematic review and network meta-analysis


Author: Yuqi Jia1, Hailiang Huang2, Ying Yu3, Hongling Jia4, Yongchen Zhang5

Affiliation: <sup>1</sup> College of Acupuncture and Massage, Shandong University of Traditional Chinese Medicine, Jinan, China.

<sup>2</sup> College of Rehabilitation Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China. 60120006@sdutcm.edu.cn.

<sup>3</sup> Institute of Chinese Medicine Innovation, Shandong University of Traditional Chinese Medicine, Jinan, China.

<sup>4</sup> Second Affiliated Hospital, Shandong University of Traditional Chinese Medicine, Jinan, China. jiahl1969@163.com.

<sup>5</sup> College of Acupuncture and Massage, Shandong University of Traditional Chinese Medicine, Jinan, China. 60050005@sdutcm.edu.cn.
Conference/Journal: Syst Rev
Date published: 2023 Dec 13
Other:
 Volume ID: 12   ,  Issue ID: 1   ,  Pages: 231   ,  Special Notes: doi: 10.1186/s13643-023-02384-1.   ,  Word Count: 434  
    Objective:

To perform an evidence-based evaluation of the clinical efficacy of Taijiquan, Baduanjin, Yijinjing and Wuqinxi in interventions for type 2 diabetes.



Design:

A systematic review and network meta-analysis.



Methods:

The comprehensive search included Chinese and other language databases such as the MEDLINE (PubMed), Web of Science, Excerpta Medica Database (Embase), The Cochrane Library, China National Knowledge Infrastructure, Wanfang Data Knowledge Service Platform, China Scientific Journal Database, VIP and China Biomedical Literature Database (CBM). Clinical randomized controlled trials of four traditional Chinese exercise therapies in the treatment of type 2 diabetes, including Taijiquan, Baduanjin, Yijinjing and Wuqinxi, were retrieved. The search time was conducted from the establishment of the database to 30 October 2022. Two researchers screened the documents that met the inclusion criteria, extracted data according to the preset table and evaluated the methodological quality of the included studies according to the quality evaluation tools recommended by the Cochrane System Reviewer Manual V.5.1. The R language, Stata and ADDIS statistical software programs were used to conduct statistics and analysis of intervention measures.



Results:

A total of 33 randomized controlled trials with 2609 patients were identified. All patients were from China. The results of the network meta-analysis showed that Taijiquan ranked the best for improving HbA1c, 2-h postprandial blood glucose (2hPG), low-density lipoprotein cholesterol (LDL-C) and insulin sensitivity index indicator levels; Yijinjing reduced fasting plasma glucose (FPG) and total cholesterol (TC) indicator levels for the best probability ranking; Baduanjin improved the triglyceride (TG) and high-density lipoprotein cholesterol (HDL-C) probability ranking the most. When the training period was less than 12 weeks, Baduanjin had better effects in improving 2hPG, TC, TG, HDL-C and LDL-C indicator levels. Taijiquan had better effects in reducing FPG levels. When the training period was 12 weeks, the effect of Yijinjing in improving FPG, HbAlc, TC and HDL-C levels was better than that in other traditional Chinese exercise, and Taijiquan had better effects in improving 2hPG, TG and LDL-C indicator levels. When the training period was longer than 12 weeks, Taijiquan had better effects in improving FPG, HbAlc, 2hPG and LDL-C indicator levels, and Baduanjin had better effects in improving TC, TG and HDL-C indicator levels.



Conclusion:

The four traditional Chinese exercise therapies can improve blood glucose levels, blood lipid levels and insulin-related indicators of type 2 diabetes to varying degrees. Studies have shown that Taijiquan has a better targeted treatment effect on type 2 diabetes.



Systematic review registration:

CRD42020214786.



Protocol published:

We published the protocol article "Network meta-analysis of four kinds of traditional Chinese exercise therapy in the treatment of type 2 diabetes: Protocol for a systematic review" in the BMJ Open magazine 2021, Issue 11, Volume 7.





PMID: 38093392 DOI: 10.1186/s13643-023-02384-1